Pfizer (PFE) Enters Collaboration Agreement with CytoReason

January 7, 2019 8:06 AM
CytoReason announced today that it has entered into a collaboration agreement with Pfizer Inc. (NYSE: PFE) that will leverage CytoReason’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Management Comments

Next Articles